SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053043
Filing Date
2020-11-10
Accepted
2020-11-10 17:15:35
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20200930.htm 10-Q 1441584
2 EX-31.1 clsd-ex311_7.htm EX-31.1 16734
3 EX-31.2 clsd-ex312_10.htm EX-31.2 16506
4 EX-32.1 clsd-ex321_6.htm EX-32.1 9052
5 GRAPHIC ggpwnacs2f2o000002.jpg GRAPHIC 33427
6 GRAPHIC ggpwnacs2f2o000001.jpg GRAPHIC 25420
  Complete submission text file 0001564590-20-053043.txt   5039945

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT clsd-20200930.xml EX-101.INS 950647
8 XBRL TAXONOMY EXTENSION SCHEMA clsd-20200930.xsd EX-101.SCH 41265
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20200930_cal.xml EX-101.CAL 36240
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20200930_def.xml EX-101.DEF 124982
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20200930_lab.xml EX-101.LAB 328318
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20200930_pre.xml EX-101.PRE 242610
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 201302160
SIC: 2834 Pharmaceutical Preparations